Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 75

Sort by

Sort Order Select

Journal Articles

Diagnosing HIT: the need for speed

Adam Cuker, Douglas B. Cines

Blood (2020) 135 (14): 1082–1083.

https://doi.org/10.1182/blood.2019004676

Published: 2020

Journal Articles

Analysis of an Online Treatment Decision Tool Reveals Variances in Practice between Experts and Oncology Healthcare Providers for Newly Diagnosed Follicular Lymphoma

Rachael M Andrie, John M Burke, MD, Christopher R. Flowers, MD MS, Nathan H Fowler, MD, Jeff P. Sharman, MD, Timothy A Quill, PhD, Kevin L Obholz, PhD, Ian W. Flinn, MD PhD

Blood (2019) 134 (Supplement_1): 414.

https://doi.org/10.1182/blood-2019-128988

Published: 2019

Journal Articles

The Revised Myeloma Comorbidity Index (R-MCI) As a Promising Approach for Predicting Overall (OS)- and Progression-Free (PFS) Survival and Optimizing Therapy Strategies in Multiple Myeloma (MM) Patients (pts) - Comparative Analysis of 5 Comorbidity Indices (CI), Including Retro- and Prospective Applicability

Katja Schoeller, Gabriele Ihorst, Sophia Scheubeck, Max Holler, Sandra M. Woerner, Heike Reinhardt, Stefan P. Müller, Justus Duyster, MD, Ralph Wäsch, MD, Monika Engelhardt, MD

Blood (2019) 134 (Supplement_1): 3474.

https://doi.org/10.1182/blood-2019-127030

Published: 2019

Journal Articles

Correlation between Changes in Granzyme B Expression and Time to Progression in Patients with Newly Diagnosed Multiple Myeloma Treated with Lenalidomide and Dexamethasone Therapy

Takahiro Kobayashi, MD PhD, Yuki Fujioka, MD PhD, Sho Ikeda, MD PhD, Hiroyoshi Nishikawa, MD PhD, Naoto Takahashi, MD PhD

Blood (2019) 134 (Supplement_1): 1792.

https://doi.org/10.1182/blood-2019-125649

Published: 2019

Journal Articles

Time-Restricted Versus Standard Duration Immunosuppression after Allogeneic Hematopoietic Stem Cell Transplantation: Results from the Prospective Randomized Phase III HOVON-96 Trial

Cornelis N. De Jong, MD, Ellen Meijer, MD PhD, Katerina Bakunina, Erfan Nur, MD PhD, Marinus van Marwijk Kooij, MD PhD, Marco De Groot, MD PhD, Michel Van Gelder, MD PhD, Johan A. Maertens, MD PhD, Jurgen H.E. Kuball, MD PhD, Dries Deeren, MD PhD, Bronno Van Der Holt, PhD, Jan J Cornelissen, MD PhD, Annoek E.C. Broers, MD PhD

Blood (2019) 134 (Supplement_1): 371.

https://doi.org/10.1182/blood-2019-130872

Published: 2019

Journal Articles

Retrospective Analysis of the Efficacy of Triplet Therapy, Including Lenalidomide, in Newly Diagnosed Multiple Myeloma Patients Who Obtained Responses Less Than VGPR after Rd Therapy

Naoki Takezako, MD PhD, Naoya Kaneko, MD, Airi Hamano, Ph, Kenichi Ito, MD, Naohiro Sekiguchi, MD, Satoshi Noto, MD, Takanori Teshima, MD

Blood (2019) 134 (Supplement_1): 5595.

https://doi.org/10.1182/blood-2019-131617

Published: 2019

Journal Articles

Perioperative Bleeding Risk Assessment in a Cohort of Children with Low Levels of Von Willebrand Factor

Berardino Pollio, Maria Messina, Irene Ricca, Mauro Pagliarino, Ugo Ramenghi, MD, Antonio Coppola, Anna Castiglione, Giovannino Ciccone, Teresa Ceglie, Anna Mondino, Paolo Tavormina, Claudia Linari

Blood (2019) 134 (Supplement_1): 2400.

https://doi.org/10.1182/blood-2019-130023

Published: 2019

Journal Articles

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

Paul La Rosée, AnnaCarin Horne, Melissa Hines, Tatiana von Bahr Greenwood, Rafal Machowicz, Nancy Berliner, Sebastian Birndt, Juana Gil-Herrera, Michael Girschikofsky, Michael B. Jordan, Ashish Kumar, Jan A. M. van Laar, Gunnar Lachmann, Kim E. Nichols, Athimalaipet V. Ramanan, Yini Wang, Zhao Wang, Gritta Janka, Jan-Inge Henter

Blood (2019) 133 (23): 2465–2477.

https://doi.org/10.1182/blood.2018894618

Published: 2019

Journal Articles

Meta-Analysis of Empirical Versus Diagnostic Driven Antifungal Strategies in Patients with Haematological Malignancies

Yayue Zhang, MD, Peng Lv, PhD, Li Hou, MD, Ken H. Young, MD PhD

Blood (2018) 132 (Supplement 1): 3727.

https://doi.org/10.1182/blood-2018-99-112885

Published: 2018

Journal Articles

Treatment Patterns and Intensity Differ between Pediatric and Adult Centers in AYA with Hodgkin's Lymphoma but Result in Equivalent Outcomes: A Population-Based Study Using the IMPACT Cohort

Sumit Gupta, MD, Nancy Baxter, MD PhD, Jason Pole, PhD, Chenthila Nagamuthu, MPH, Cindy Lau, MPH, Rinku Sutradhar, PhD, Paul Nathan, MD

Blood (2018) 132 (Supplement 1): 831.

https://doi.org/10.1182/blood-2018-99-117321

Published: 2018

Journal Articles

Durable Remissions Achieved with R-CHOP Chemotherapy without Radiotherapy in Patients with Primary Mediastinal B-Cell Lymphoma - the Royal Marsden Experience

Vasiliki Michalarea, MD, Dima El-Sharkawi, MBBS BSc FRCPath MD, Siraj Yusuf, Mary Gleeson, Laura Hickmott, Andrew Wotherspoon, Ayoma Attygalle, Simon O'Connor, Bhupinder Sharma, Yong Du, Imene Zerizer, Alan Horwich, Gillian Ross, Andrea Kuhnl, Sunil Iyengar, Ian Chau, MD, David Cunningham

Blood (2018) 132 (Supplement 1): 4240.

https://doi.org/10.1182/blood-2018-99-119560

Published: 2018

Journal Articles

The Use of EUTOS Long-Term Survival Score Instead of Sokal Score Is Strongly Advised in Elderly Chronic Myeloid Leukemia Patients

Blood (2018) 132 (Supplement 1): 44.

https://doi.org/10.1182/blood-2018-99-117409

Published: 2018

Journal Articles

Histiocytic Necrotizing Lymphadenitis, a Benign Mimic of Lymphoma Presenting with B Symptoms

Varsha Gupta, MD, Shreya Gor, MD, Anmol S Cheema, MD, Ravneet Bajwa, MD, Carrie Edelman, MD, Ethan Jeffrey Wasserman, MD

Blood (2018) 132 (Supplement 1): 4949.

https://doi.org/10.1182/blood-2018-99-118826

Published: 2018

Journal Articles

Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group

Shun-Ichi Kimura, MD PhD, Yoshinobu Kanda, MD PhD, Masaki Iino, MD PhD, Takahiro Fukuda, MD PhD, Emiko Sakaida, MD PhD, Tatsuo Oyake, Hiroki Yamaguchi, MD PhD, Shin-ichiro Fujiwara, MD PhD, Junji Suzumiya, MD PhD, Akinao Okamoto, MD PhD, Hiroyuki Fujita, MD PhD, Yasushi Takamatsu, MD PhD, Yoshio Saburi, MD PhD, Jun Yamanouchi, MD PhD, Itaru Matsumura, MD, Souichi Shiratori, Moritaka Gotoh, MD PhD, Shingen Nakamura, MD PhD, Kazuo Tamura, MD PhD

Blood (2018) 132 (Supplement 1): 816.

https://doi.org/10.1182/blood-2018-99-111154

Published: 2018

Journal Articles

Optimizing therapy in advanced-stage Hodgkin lymphoma

Sean H. Lim, Peter W. M. Johnson

Blood (2018) 131 (15): 1679–1688.

https://doi.org/10.1182/blood-2017-09-772640

Published: 2018

Journal Articles

Prognostic Impact of Extranodal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma

David Kasouha, Nicola Lehners, MD, Katharina Kriegsmann, MD MBA, Gerlinde Egerer, Anthony D. Ho, Mathias Witzens-Harig, MD MHBA

Blood (2017) 130 (Supplement 1): 2855.

https://doi.org/10.1182/blood.V130.Suppl_1.2855.2855

Published: 2017

Journal Articles

Diagnosis and Management of Heparin Induced Thrombocytopenia — Are We Choosing Wisely?

Pallavi Kopparthy, MD, Alina Basnet, MBBS, Stephen Graziano, MD, Cheryl A Roe, MS

Blood (2017) 130 (Supplement 1): 4653.

https://doi.org/10.1182/blood.V130.Suppl_1.4653.4653

Published: 2017

Journal Articles

Evaluation of Platelet Parameters in Children

Ralf Knoefler, MD, Stefanie Hackel, Julia Staechele, MD, Judith Lohse, MD, Ursula Range, Meinolf Suttorp, PhD MD, Oliver Tiebel, MD

Blood (2017) 130 (Supplement 1): 4842.

https://doi.org/10.1182/blood.V130.Suppl_1.4842.4842

Published: 2017

Journal Articles

Heparin-Induced Thrombocytopenia: Are We Ordering Too Much

Sandy El Bitar, MD, Elias Moussaly, MD, Saqib Abbasi, MD, Sassine Ghanem, MD, Bassel Nazha, MD, Gwenalyn Garcia, MD, Terenig Terjanian, MD

Blood (2017) 130 (Supplement 1): 2332.

https://doi.org/10.1182/blood.V130.Suppl_1.2332.2332

Published: 2017

Journal Articles

Molecular Responses after Switching from a Standard-Dose Twice-Daily Nilotinib Regimen to a Reduced-Dose Once-Daily Schedule in Patients with Chronic Myeloid Leukemia: A Real Life Observational Study (NILO-RED)

Delphine Rea, MD, Jean-Michel Cayuela, PhD, Stephanie Dulucq, PhD, Gabriel Etienne, MD PhD

Blood (2017) 130 (Supplement 1): 318.

https://doi.org/10.1182/blood.V130.Suppl_1.318.318

Published: 2017

NARROW

Diagnosing HIT: the need for speed

Analysis of an Online Treatment Decision Tool Reveals Variances in Practice between Experts and Oncology Healthcare Providers for Newly Diagnosed Follicular Lymphoma

Correlation between Changes in Granzyme B Expression and Time to Progression in Patients with Newly Diagnosed Multiple Myeloma Treated with Lenalidomide and Dexamethasone Therapy

Time-Restricted Versus Standard Duration Immunosuppression after Allogeneic Hematopoietic Stem Cell Transplantation: Results from the Prospective Randomized Phase III HOVON-96 Trial

Retrospective Analysis of the Efficacy of Triplet Therapy, Including Lenalidomide, in Newly Diagnosed Multiple Myeloma Patients Who Obtained Responses Less Than VGPR after Rd Therapy

Perioperative Bleeding Risk Assessment in a Cohort of Children with Low Levels of Von Willebrand Factor

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

Meta-Analysis of Empirical Versus Diagnostic Driven Antifungal Strategies in Patients with Haematological Malignancies

Treatment Patterns and Intensity Differ between Pediatric and Adult Centers in AYA with Hodgkin's Lymphoma but Result in Equivalent Outcomes: A Population-Based Study Using the IMPACT Cohort

Durable Remissions Achieved with R-CHOP Chemotherapy without Radiotherapy in Patients with Primary Mediastinal B-Cell Lymphoma - the Royal Marsden Experience

The Use of EUTOS Long-Term Survival Score Instead of Sokal Score Is Strongly Advised in Elderly Chronic Myeloid Leukemia Patients

Histiocytic Necrotizing Lymphadenitis, a Benign Mimic of Lymphoma Presenting with B Symptoms

Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group

Optimizing therapy in advanced-stage Hodgkin lymphoma

Prognostic Impact of Extranodal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Diagnosis and Management of Heparin Induced Thrombocytopenia — Are We Choosing Wisely?

Evaluation of Platelet Parameters in Children

Heparin-Induced Thrombocytopenia: Are We Ordering Too Much

Molecular Responses after Switching from a Standard-Dose Twice-Daily Nilotinib Regimen to a Reduced-Dose Once-Daily Schedule in Patients with Chronic Myeloid Leukemia: A Real Life Observational Study (NILO-RED)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only